CLINICAL_TRIALS
trial_result
· 2012-12-07
Clinical Trial Update: Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis [Phase 2]
Summary
A Phase 2 trial evaluates the safety and efficacy of IV TZP-101 in adults with severe diabetic gastroparesis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tranzyme, Inc. | Conditions: Gastroparesis, Diabetes Mellitus | Phase 2 | Status: COMPLETED